Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00503347
What this trial is testing

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Who this might be right for
Hepatitis C VirusHiv Infections
Peregrine Pharmaceuticals 24
Not applicableStudy completedNCT02786758
What this trial is testing

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals

Who this might be right for
Hepatitis CHIV
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 200
Testing effectiveness (Phase 2)Study completedNCT00324389
What this trial is testing

Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes

Who this might be right for
Hepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableStudy completedNCT01423643
What this trial is testing

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

Who this might be right for
HIV InfectionHepatitis C
Johns Hopkins University 1,250
Not applicableUnknownNCT03941821
What this trial is testing

Glecaprevir/Pibrentasvir Real-world Study in China

Who this might be right for
Chronic Hepatitis c
Tongji Hospital 800
Early research (Phase 1)Study completedNCT00635804
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 60
Not applicableEnded earlyNCT00340548
What this trial is testing

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Who this might be right for
HemophiliaAIDS
National Cancer Institute (NCI) 333
Large-scale testing (Phase 3)UnknownNCT02961426
What this trial is testing

Strategic Transformation of the Market of HCV Treatments

Who this might be right for
Hepatitis C
Drugs for Neglected Diseases 603
Not applicableStudy completedNCT00575315
What this trial is testing

HIV-HCV Coinfection: Impact of Immune Dysfunction

Who this might be right for
HIV InfectionsHepatitis
Virginia Commonwealth University 634
Testing effectiveness (Phase 2)UnknownNCT04189276
What this trial is testing

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B Virus (HBV)
Tasly Tianjin Biopharmaceutical Co., Ltd. 100
Post-approval studies (Phase 4)Study completedNCT03512210
What this trial is testing

Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection

Who this might be right for
Hepatitis CHIV-1-infectionLiver Diseases
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 400
Testing effectiveness (Phase 2)Study completedNCT01605513
What this trial is testing

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

Who this might be right for
Hepatitis C Virus
The First Hospital of Jilin University 80
Testing effectiveness (Phase 2)UnknownNCT04073459
What this trial is testing

Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 336
Not applicableStudy completedNCT05138523
What this trial is testing

Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)

Who this might be right for
Chronic Hepatitis c
Beker Laboratories 99
Early research (Phase 1)Looking for participantsNCT06455280
What this trial is testing

SIPLIZUMAB in AILD and LT Patients

Who this might be right for
Autoimmune Liver DiseaseLiver Transplant DisorderAutoimmune Hepatitis+3 more
Elizabeth C. Verna 8
Large-scale testing (Phase 3)Study completedNCT02600117
What this trial is testing

Use of TDF in Patients With Inactive Chronic Hepatitis B Infection

Who this might be right for
Hepatitis B, Chronic
University Health Network, Toronto 50
Large-scale testing (Phase 3)Study completedNCT00100659
What this trial is testing

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 114
Post-approval studies (Phase 4)Ended earlyNCT01082861
What this trial is testing

Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination

Who this might be right for
Human Papillomavirus Infection
National Institute for Public Health and the Environment (RIVM)
Not applicableUnknownNCT00272389
What this trial is testing

Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile

Who this might be right for
Hepatitis C Virus Chronic Infection
Hadassah Medical Organization 150
Not applicableStudy completedNCT02597790
What this trial is testing

A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects

Who this might be right for
HIVHepatitis C
University of California, Los Angeles 87
Next Page